Profound Medical Corp.
NASDAQ:PROF
8.96 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -29.093 | -28.669 | -30.699 | -21.622 | -15.458 | -15.244 | -14.968 | -12.147 | -11.801 | -8.204 |
| Depreciation & Amortization
| 1.167 | 1.604 | 1.879 | 1.538 | 1.542 | 1.229 | 0.693 | 0.139 | 0.086 | 0.085 |
| Deferred Income Tax
| -4.984 | 0 | -0.293 | 0.237 | 0.12 | -0.071 | 0 | 0.008 | -1.548 | 0 |
| Stock Based Compensation
| 3.417 | 4.238 | 7.205 | 3.018 | 1.266 | 0.797 | 1.064 | 0.745 | 0.465 | 0.19 |
| Change In Working Capital
| 0.381 | -5.629 | -0.877 | -4.635 | -3.735 | -0.991 | -0.502 | -0.152 | 0.311 | 0 |
| Accounts Receivables
| -0.974 | -1.368 | 1.996 | -4.028 | -1.05 | 1.149 | -3.169 | -0.612 | 0 | 0 |
| Inventory
| 0.359 | -1.864 | -2.491 | -2.141 | -0.867 | -1.616 | -0.807 | -0.31 | 0 | 0 |
| Accounts Payables
| 1.381 | -0.566 | -0.356 | 0.102 | -0.018 | -0.857 | 2.679 | 0.577 | -0.065 | 0 |
| Other Working Capital
| -0.386 | -1.831 | -0.026 | 1.432 | -1.799 | 0.332 | 0.795 | 0.193 | 0.377 | 0 |
| Other Non Cash Items
| 6.406 | 2.656 | 0.425 | 0.89 | 0.914 | 0.847 | 1.899 | 0.617 | 7.543 | 5.05 |
| Operating Cash Flow
| -22.706 | -25.8 | -22.36 | -20.574 | -15.334 | -13.432 | -11.813 | -10.79 | -4.944 | -2.879 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | -0.593 | -0.35 | -0.191 | 0 | -0.37 | -0.809 | -0.12 | -0.061 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | -0.424 | 0 | 0.834 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7.206 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | -0.709 | -0.445 | -0.245 | 0 | -0 | 7.44 | -0 | 0 |
| Investing Cash Flow
| 0.269 | 0 | -0.593 | -0.35 | -0.191 | 0 | -0.793 | 6.631 | -6.492 | -0.061 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -0.929 | -0.356 | -0.386 | -9.606 | -1.263 | -4.296 | -2.877 | -0.213 | -0.557 | -0.5 |
| Common Stock Issued
| 2.717 | 0.253 | 6.376 | 85.523 | 8.804 | 25.33 | 7.952 | 12.947 | 17.301 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.297 | 7.134 | -0.042 | 11.516 | -0.792 | 6.777 | 8.999 | -0.904 | 1.981 | 3.241 |
| Financing Cash Flow
| 1.491 | 7.031 | 5.948 | 87.433 | 6.749 | 27.81 | 6.122 | 11.829 | 18.726 | 2.741 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0.529 | -1.866 | 0.244 | 2.604 | 0 | 0 | 0 | 0 | 0 | 2.94 |
| Net Change In Cash
| -20.417 | -20.635 | -16.761 | 69.113 | -8.777 | 14.379 | -7.737 | 7.671 | 7.29 | 2.741 |
| Cash At End Of Period
| 26.079 | 46.517 | 67.152 | 83.913 | 14.715 | 22.53 | 8.83 | 15.5 | 7.583 | 3.347 |